Merging biophysics with knowledge of how the brain handles waste led to an impressive 50 percent reduction of amyloid beta in ...

A new study suggests that the blood-brain barrier (BBB) remains intact in a widely used mouse model of Alzheimer’s disease.

A new drug targeting inflammation in the brain has been shown to bolster the blood-brain barrier in mice, pioneering a potential shift in the fight against neurodegenerative diseases like Alzheimer's.

Spanish and Chinese scientists say they have used nanoparticles to enable the brains of mice to clear out plaque linked to ...

A new nanomedicine targeting the blood–brain barrier clears amyloid-β by 45% and restores memory in Alzheimer’s models, ...

A nanotechnology strategy has shown promise to reverse Alzheimer’s disease in mice. The study presents “supramolecular drugs,” a novel class of nanoparticles that function as medicines on their own, ...

Therapy using polymersome technology restores BBB transport function rather than acting on the neurons or other brain cells.

A new study from Texas Tech University Health Sciences Center suggests that the brain’s protective barrier remains intact ...

“This is an innovative early-stage approach with encouraging results in mice. The rapid clearance of amyloid and the behavioural improvements are particularly striking. As with any preclinical study, ...

A common blood test can flag early Alzheimer's disease patients who are four times more likely to experience rapid brain decline, a new study says. The test -- the triglyceride-glucose (TyG) index -- ...

A 2025 BMJ study came to similar conclusions. It suggests that people who have had a previous case of HSV-1 are 80 percent ...